Access Bio, Inc. (KOSDAQ: 950130)
South Korea
· Delayed Price · Currency is KRW
5,890.00
-150.00 (-2.48%)
Jan 22, 2025, 9:00 AM KST
Access Bio Revenue
Access Bio had revenue of 21.70B KRW in the quarter ending September 30, 2024, with 611.17% growth. This brings the company's revenue in the last twelve months to 118.85B, down -67.21% year-over-year. In the year 2023, Access Bio had annual revenue of 348.64B, down -66.28%.
Revenue (ttm)
118.85B
Revenue Growth
-67.21%
P/S Ratio
1.64
Revenue / Employee
1.18B
Employees
101
Market Cap
204.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 348.64B | -685.22B | -66.28% |
Dec 31, 2022 | 1,033.86B | 528.75B | 104.68% |
Dec 31, 2021 | 505.11B | 383.31B | 314.71% |
Dec 31, 2020 | 121.80B | 78.74B | 182.86% |
Dec 31, 2019 | 43.06B | 2.82B | 7.01% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |